/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE
SERVICES/
LONDON, ON, Sept. 22, 2021 /CNW/ - Indiva Limited (the
"Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF),
the leading Canadian producer of cannabis edibles and other
cannabis products, is pleased to announce that it is introducing a
warrant exercise incentive program (the "Incentive Program")
designed to encourage the early exercise of up to 17,184,996
outstanding common share purchase warrants (the
"Warrants").
The Warrants eligible for the Incentive Program, as set out in
the following table, were issued in connection with a private
placement offering of units, with each unit consisting of one
common share in the capital of the Company ("Common Shares")
and one Warrant (the "Offering"). The Offering was completed
in two tranches occurring on June 25,
2020 and August 10, 2020:
Issue
Date
|
Expiry
Date
|
Warrants
Outstanding
|
Exercise Price
($)
|
June 25,
2020
|
June 25,
2023
|
3,294,333
|
0.40
|
August 10,
2020
|
August 10,
2023
|
13,890,663
|
0.40
|
Under the terms of the Incentive Program, for each Warrant that
is exercised on or before October 12,
2021 (the "Early Exercise Period"), the holder
thereof will receive, at no additional cost, one-half of one newly
issued common share purchase warrant (each an "Incentive
Warrant"), with each whole Incentive Warrant exercisable into
one common share for a period of five (5) years from the issue date
at an exercise price of $0.45.
The gross proceeds to the Company, if all of the Warrants are
exercised, would be $6,873,998.40.
There is no assurance that all or any of the Warrants will be
exercised.
The terms and conditions of the Incentive Program, including the
method of exercising the Warrants, will be set forth in a letter to
be delivered shortly to the registered holders of the Warrants.
Any Warrants that are not exercised prior to the expiry of the
Early Exercise Period will remain outstanding in accordance with
their original terms, and in particular, will no longer be eligible
for the issuance of Incentive Warrants.
A portion of the Warrants, eligible for participation in the
Incentive Program, are held by insiders of the Company.
Participation by any such insiders in the Incentive Program may
constitute a related party transaction pursuant to Multilateral
Instrument 61-101 – Special Transactions ("MI
61-101"). The Company is exempt from the formal valuation
requirement pursuant to subsections 5.5(a) and (b) of MI 61-101,
and from the minority approval requirement pursuant to subsection
5.7(1)(a) of MI 61-101.
The Incentive Program is subject to the receipt of applicable
regulatory approvals, including the approval of the TSX Venture
Exchange.
ABOUT INDIVA
Indiva sets the standard for quality and innovation in cannabis.
As a Canadian licensed producer, Indiva produces and distributes
award-winning cannabis products nationally, including
Bhang® Chocolate, Wana™ Sour Gummies, Slow
Ride Bakery Cookies, Jewels Chewable Tablets, Ruby®
Cannabis Sugar, Sapphire™ Cannabis Salt, as well as capsules,
pre-rolls and premium flower under the INDIVA and Artisan Batch
brands. Click here to connect with Indiva on LinkedIn, Instagram,
Twitter and Facebook, and here to find more information on the
Company and its products.
DISCLAIMER AND READER ADVISORY
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This news release contains "forward-looking information" within
the meaning of the applicable Canadian securities legislation which
involves known and unknown risks relevant to the Company in
particular and to the biotechnology and pharmaceutical industries
in general, uncertainties and other factors that may cause actual
events to differ materially from current expectation. These risks
are more fully described in the Company's public filings available
at www.sedar.com. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. The Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
The securities offered have not been, and will not be,
registered under the U.S. Securities Act or any U.S. state
securities laws, and may not be offered or sold in the United States absent registration or an
applicable exemption from the registration requirements of the U.S.
Securities Act and applicable U.S. state securities laws. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy securities in the United States, nor shall there be any sale
of these securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful.
SOURCE Indiva Limited